Annual Total Long Term Liabilities
$11.21 M
+$2.02 M+21.93%
December 31, 2023
Summary
- As of March 6, 2025, INKT annual total long term liabilities is $11.21 million, with the most recent change of +$2.02 million (+21.93%) on December 31, 2023.
- During the last 3 years, INKT annual total long term liabilities has fallen by -$33.00 million (-74.65%).
- INKT annual total long term liabilities is now -74.65% below its all-time high of $44.21 million, reached on December 31, 2020.
Performance
INKT Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$17.53 M
+$777.40 K+4.64%
September 30, 2024
Summary
- As of March 6, 2025, INKT quarterly total long term liabilities is $17.53 million, with the most recent change of +$777.40 thousand (+4.64%) on September 30, 2024.
- Over the past year, INKT quarterly long term liabilities has stayed the same.
- INKT quarterly long term liabilities is now -60.35% below its all-time high of $44.21 million, reached on December 31, 2020.
Performance
INKT Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
INKT Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +21.9% | 0.0% |
3 y3 years | -74.7% | 0.0% |
5 y5 years | -62.9% | 0.0% |
INKT Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | -100.0% | at high | -100.0% |
5 y | 5-year | -74.7% | -100.0% | -60.4% | -100.0% |
alltime | all time | -74.7% | -100.0% | -60.4% | -100.0% |
MiNK Therapeutics Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $17.53 M(+4.6%) |
Jun 2024 | - | $16.75 M(+4.1%) |
Mar 2024 | - | $16.08 M(+43.5%) |
Dec 2023 | $11.21 M(+21.9%) | $11.21 M(+5.2%) |
Sep 2023 | - | $10.65 M(+5.0%) |
Jun 2023 | - | $10.14 M(+3.3%) |
Mar 2023 | - | $9.81 M(+6.8%) |
Dec 2022 | $9.19 M | $9.19 M(>+9900.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $58.30 K(>+9900.0%) |
Jun 2022 | - | $0.00(0.0%) |
Mar 2022 | - | $0.00(0.0%) |
Dec 2021 | $0.00(-100.0%) | $0.00(-100.0%) |
Sep 2021 | - | $27.50 K(-92.8%) |
Jun 2021 | - | $383.10 K(-99.1%) |
Dec 2020 | $44.21 M(+46.3%) | $44.21 M |
Dec 2019 | $30.22 M | - |
FAQ
- What is MiNK Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for MiNK Therapeutics?
- What is MiNK Therapeutics annual total long term liabilities year-on-year change?
- What is MiNK Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for MiNK Therapeutics?
- What is MiNK Therapeutics quarterly long term liabilities year-on-year change?
What is MiNK Therapeutics annual total long term liabilities?
The current annual total long term liabilities of INKT is $11.21 M
What is the all time high annual total long term liabilities for MiNK Therapeutics?
MiNK Therapeutics all-time high annual total long term liabilities is $44.21 M
What is MiNK Therapeutics annual total long term liabilities year-on-year change?
Over the past year, INKT annual total long term liabilities has changed by +$2.02 M (+21.93%)
What is MiNK Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of INKT is $17.53 M
What is the all time high quarterly long term liabilities for MiNK Therapeutics?
MiNK Therapeutics all-time high quarterly total long term liabilities is $44.21 M
What is MiNK Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, INKT quarterly total long term liabilities has changed by $0.00 (0.00%)